GROVES REGINA E
SEC insider (Form 3/4/5 filer). CIK 0001653877. Director at AtriCure, Inc. (ATRC) and 1 other issuer. 6 reported Form 4/5 transactions since Sep 2024; latest on Sep 11, 2026. Located in MASON, OH.
Companies GROVES REGINA E has filed insider reports for
- AtriCure, Inc. (ATRC): Director
- Fulgent Genetics, Inc. (FLGT): Director
GROVES REGINA E
CIK: 0001653877
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)2 (33.3%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)4 (66.7%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (6 total)
- Sep 11, 2026ATRC
AtriCure, Inc.
SaleDirect5.3K shares at avg. $54.22$288K - May 18, 2026ATRC
AtriCure, Inc.
AwardDirect6.1K shares- - May 14, 2026FLGT
Fulgent Genetics, Inc.
AwardDirect11.1K shares- - Aug 6, 2025ATRC
AtriCure, Inc.
SaleDirect2.5K shares at avg. $36.82$90K - May 19, 2025ATRC
AtriCure, Inc.
AwardDirect5.4K shares- - May 15, 2025FLGT
Fulgent Genetics, Inc.
AwardDirect9K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 11, 2026 |  ATRC AtriCure, Inc. | Sale | 5,313 | $54.22 | $288,071 | Direct |
| May 18, 2026 | ATRC AtriCure, Inc. | Award | 6,144 | - | $0 | Direct |
| May 14, 2026 |  FLGT Fulgent Genetics, Inc. | Award | 11,117 | - | $0 | Direct |
| Aug 6, 2025 | ATRC AtriCure, Inc. | Sale | 2,452 | $36.82 | $90,283 | Direct |
| May 19, 2025 | ATRC AtriCure, Inc. | Award | 5,401 | - | - | Direct |
| May 15, 2025 | FLGT Fulgent Genetics, Inc. | Award | 8,982 | - | - | Direct |
1-6 of 6 transactions